Navigation Links
VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
Date:12/23/2011

tners; the timing of initiation and completion of clinical trials and submissions to the FDA or foreign authorities; the volatility and liquidity of the financial markets; our liquidity and capital resources; and our expected future revenues, operations and expenditures.  As with any pharmaceutical in development, there are significant risks in the development, the regulatory approval, and commercialization of new products. There are no guarantees that our response to the FDA's CRL or CHMP's 120-day questions, the FDA's requests stemming from the end-of-review meeting or the results of the retrospective observational study of fetal outcomes in infants born to mothers exposed to topiramate during pregnancy and subsequent meetings and communications will be sufficient to satisfy the FDA or CHMP's safety concerns, that the FDA or foreign authorities will not require us to conduct any additional prospective studies or retrospective observational studies, or that any product will receive regulatory approval for any indication or prove to be commercially successful.  VIVUS does not undertake an obligation to update or revise any forward-looking statements.  Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2010, and periodic reports filed with the Securities and Exchange Commission. 

 

 CONTACT:  

  

 

 VIVUS, Inc. Investor Relations: The Trout GroupTimothy E. Morris

 

Brian Korb Chief Financial Officer 

646-378-2923morris@vivus.com

 

bkorb@troutgroup.com 


'/>"/>
SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Results From Phase 3 EQUATE Trial of VIVUS Qnexa Highlighted at European Congress on Obesity
2. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
3. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
4. VIVUS Announces Promotion of Peter Tam to President
5. VIVUS to Present at Lazard Capital Markets Healthcare Conference
6. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
7. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
8. VIVUS Announces Sale of MUSE Assets to Meda
9. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
10. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
11. VIVUS to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 ... research report is available in its ... Markets and Technologies for Advanced Drug ... of Administration ...
(Date:1/15/2014)...  A novel wearable injector slightly larger than an Oreo cookie ... self-inject prescription drugs in the large doses required to treat ... deficiencies, and genetic disorders.  An emerging biologic ... according to analysts.   Many of these drugs will require a ...
(Date:1/14/2014)... 2014  Luminex Corporation (Nasdaq: LMNX ) today announced ... of 2013 on Monday, February 3, 2014. A press release ... of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... operating highlights and financial results for the fourth quarter and ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... March 25, 2011 Soles4Souls, the international shoe charity ... their proceeds from orders to Soles4Souls, to help provide ... 9.0 magnitude earthquake that rocked Japan on March 9, ... Pharmacy; call 877-323-9803 for your prescriptions, medical supplies, and ...
... AssureRx Health, Inc. today announced the closing ... medicine company, which provides clinically-relevant information to help physicians ... individual neuropsychiatric patients, will use the funds to expand ... GeneSightRx®, and for second generation product development activities. ...
Cached Medicine Technology:PromiseCare Pharmacy Donates to Soles4Souls® Japanese Relief Efforts 2AssureRx Health Raises $11 Million Series B Financing 2AssureRx Health Raises $11 Million Series B Financing 3AssureRx Health Raises $11 Million Series B Financing 4
(Date:4/23/2014)... known as Ritalin, may prevent the depletion of self-control, ... a journal of the Association for Psychological Science. , ... or trying to focus attention on a boring textbook ... potential explanation for this difficulty: Exerting self-control for a ... self-control effectively on subsequent tasks. , "It is as ...
(Date:4/22/2014)... the United States with 1 million participants annually. A ... Injury Research and Policy at Nationwide Children,s Hospital is ... distribution patterns of basketball-related injuries treated in emergency departments ... and teens. , The study, published online in the ... to adolescents 13-19 years of age who were treated ...
(Date:4/22/2014)... last few decades researchers have characterized a set of ... behavior in all types of species, from flies to ... but researchers surmise there are more. A team from ... Pennsylvania wondered if big-data approaches could find them. ... John Hogenesch, PhD, professor of Pharmacology and first author ...
(Date:4/22/2014)... all lung cancers are small cell lung cancers ... to chemotherapy. However, researchers at Virginia Commonwealth University ... the mechanisms leading to this resistance that may ... primarily by mediating B-cell lymphoma 2 (Bcl-2) family ... Depending on their function, this family of proteins ...
(Date:4/22/2014)... 2014) The International Communication Association will hold ... Washington. The theme of the 2014 conference will ... networked and digital society. , Featuring over 2,300 ... 2,200 Communication scholars representing over 40 countries, the ... conference in the world. This year,s conference features ...
Breaking Medicine News(10 mins):Health News:ADHD drug may help preserve our self-control resources 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 3Health News:Bioinformatics profiling identifies a new mammalian clock gene 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:International Communication Association to hold Annual Conference in Seattle, Washington 2
... Health Services, Inc. (NYSE: UHS ) announced ... a cash dividend of $0.08 per share on June ... 1, 2009.Universal Health Services, Inc. is one of the ... care and behavioral health hospitals, and ambulatory centers nationwide ...
... Examined For Skin CancerYONKERS, N.Y., May 20 Thirty-one percent of ... National Research Center said they never wear sunscreen. ... of those polled said they,d been examined by a doctor for ... of Consumer Reports rates ten top selling sunscreens to ...
... the strain is related to flu variant that circulated before ... people may have partial immunity to the new H1N1 swine ... strain circulating prior to 1957, a U.S. infectious-disease expert said ... more likely you are to have been exposed to H1N1 ...
... when even teens who have never tried a drop of alcohol ... big events and there will be multiple parties to attend and ... , Assume that your child will be tempted to drink alcohol ... Inside Alcohol Project of the American Association for the Advancement of ...
... Small Business Membership process, which eliminates more than a dozen formal ... qualify with a business card or letterhead. , ... ... series of pro-small business initiatives aimed to help small business owners ...
... Orasi Medical, Inc. announced today that it has completed ... use this capital to expand the development and use ... markets. Pharmaceutical companies will use this test to determine ... diseases. Orasi is currently in discussions with several pharmaceutical ...
Cached Medicine News:Health News:Consumer Reports Poll: Thirty-One Percent of Americans Never Use Sunscreen 2Health News:Consumer Reports Poll: Thirty-One Percent of Americans Never Use Sunscreen 3Health News:Consumer Reports Poll: Thirty-One Percent of Americans Never Use Sunscreen 4Health News:Older Adults May Have Some Immunity to Swine Flu 2Health News:Older Adults May Have Some Immunity to Swine Flu 3Health News:Older Adults May Have Some Immunity to Swine Flu 4Health News:Older Adults May Have Some Immunity to Swine Flu 5Health News:Older Adults May Have Some Immunity to Swine Flu 6Health News:Older Adults May Have Some Immunity to Swine Flu 7Health News:Older Adults May Have Some Immunity to Swine Flu 8Health News:Older Adults May Have Some Immunity to Swine Flu 9Health News:Older Adults May Have Some Immunity to Swine Flu 10Health News:Older Adults May Have Some Immunity to Swine Flu 11Health News:Older Adults May Have Some Immunity to Swine Flu 12Health News:Older Adults May Have Some Immunity to Swine Flu 13Health News:Use science to convince teens a sober prom is better, AAAS says 2Health News:National Small Business Week Update: Sam's Club Announces Simplified Small Business Membership; Partnership With U.S. Chamber of Commerce, Plus Free One-Day Pass 2Health News:National Small Business Week Update: Sam's Club Announces Simplified Small Business Membership; Partnership With U.S. Chamber of Commerce, Plus Free One-Day Pass 3
First to USA-market, this revolutionary technology combines CBC and CRP analysis for stat results of 17 parameters within 4.5 minutes!...
StarClose Clip Applier, (includes), Clip Applier, 6F Exchange Sheath, 6F Dilator, 0.038 50 cm J-Tip Guide Wire ...
... 5.5x magnification., ,Higher magnification for advanced ... true image. Edge to edge clarity ... for intricate surgical applications. The XL's ... anti-reflective coating to produce a superior ...
... and 3.0x magnification. The true benefit of ... while maintaining focal clarity is made possible ... The lightweight aluminum bar and individual pupillary ... and optimal focal alignment, eliminating headache and ...
Medicine Products: